Introduction {#sec1-2396987318818779}
============

Nonfocal transient neurological attacks (TNAs) are defined as attacks with atypical, nonlocalizing cerebral symptoms such as unsteadiness, confusion or bilateral weakness.^[@bibr1-2396987318818779],[@bibr2-2396987318818779]^ Patients with nonfocal TNAs are at higher risk of cardiac events, stroke and dementia than patients without nonfocal TNAs.^[@bibr2-2396987318818779],[@bibr3-2396987318818779]^ Even though they are by no means benign, the underlying pathophysiology of nonfocal TNAs is still poorly understood. Both cerebral ischemia and cerebral hypoperfusion have been suggested to play a role.^[@bibr1-2396987318818779],[@bibr3-2396987318818779][@bibr4-2396987318818779]--[@bibr5-2396987318818779]^ Factors that might contribute to cerebral hypoperfusion are severe obstruction of cerebropetal arteries and impaired cerebral autoregulation.^[@bibr6-2396987318818779]^ We therefore hypothesized that in patients with carotid artery occlusion (CAO), nonfocal TNAs are more prevalent than in patients without CAO.

Methods {#sec2-2396987318818779}
=======

Study population and design {#sec3-2396987318818779}
---------------------------

We selected patients from two prospective observational cohort studies.^[@bibr7-2396987318818779],[@bibr8-2396987318818779]^

Patients with CAO were selected from the Heart-Brain Connection (HBC) study, which is a multicenter cohort study in the Netherlands that focusses on the relation between cardiovascular and hemodynamic measures and cognitive impairment.^[@bibr7-2396987318818779]^ From all consecutive patients with CAO who participated in the HBC study from November 2014 to March 2017 (data release 1 October 2017), we included all patients with CAO who had experienced an ipsilateral transient ischemic attack (TIA) or nondisabling ischemic stroke more than six months before inclusion. CAO was defined as a complete occlusion of the internal carotid artery and was measured either with ultrasound, magnetic resonance angiography or computed tomography angiography.

Patients without CAO were selected from the Second Manifestations of ARTerial disease (SMART) study from November 2015 until September 2017. The SMART study is a cohort study executed by a single academic hospital in the Netherlands, including patients with vascular risk factors or clinical manifest vascular disease.^[@bibr8-2396987318818779]^ Eligible patients had a history of TIA or nondisabling ischemic stroke of the anterior circulation that had occurred more than six months before inclusion and did not have a stenosis of the ipsilateral or contralateral carotid artery of ≥50% on ultrasound. Imaging of the internal carotid arteries was performed \<1 year before inclusion into our study.

In both groups, patients were independent in activities of daily living (modified Rankin Scale of 0--3).

The HBC study and SMART study were approved by the Ethics Committee of the Leiden UMC and UMC Utrecht, respectively.^[@bibr7-2396987318818779],[@bibr8-2396987318818779]^ All patients provided written informed consent.

Study parameters {#sec4-2396987318818779}
----------------

All patients were interviewed by a trained physician or research nurse with a standardized questionnaire on the occurrence of eight nonfocal symptoms in the preceding six months ([Table 1](#table1-2396987318818779){ref-type="table"}). Nonfocal TNAs were defined as attacks of one or more nonfocal signs or symptoms with an acute onset, a minimum duration of 30 s and a maximum of 24 h. The classification of nonfocal symptoms was adapted from the Rotterdam Study.^[@bibr1-2396987318818779],[@bibr2-2396987318818779]^ Symptoms that were compatible with a different diagnosis, such as migraine or epilepsy, were excluded from the analysis. The researcher who completed the interview was aware of the presence or absence of CAO in each patient.

###### 

Occurrence of different types of nonfocal TNA symptoms in the past six months.

![](10.1177_2396987318818779-table1)

  Nonfocal symptoms, *n* (%)   Carotid occlusion (*n* = 67)   No carotid occlusion (*n* = 62)
  ---------------------------- ------------------------------ ---------------------------------
  Blurred vision               6 (9%)                         2 (3%)
  Bilateral leg weakness       4 (6%)                         1 (2%)
  Unsteadiness                 6 (9%)                         0 (0%)
  Nonrotatory dizziness        18 (27%)                       13 (21%)
  Paresthesias                 0 (0%)                         4 (7%)
  Unconsciousness              4 (6%)                         0 (0%)
  Confusion                    2 (3%)                         0 (0%)
  Amnesia                      1 (2%)                         0 (0%)

TNA: transient neurological attack.

In addition, we recorded demographic and clinical characteristics, including the presence of vascular risk factors, use of antihypertensive, lipid lowering, antiplatelet or anticoagulant medication, blood pressure, side of symptomatic CAO and presence of other extracranial arterial stenosis.

Statistical analysis {#sec5-2396987318818779}
--------------------

We calculated the prevalence of nonfocal TNAs in both patient groups. We assessed the association between CAO and the occurrence of nonfocal TNAs with Poisson regression analysis with robust standard errors.^[@bibr9-2396987318818779]^ We calculated crude and adjusted risk ratios (RR) with corresponding 95% confidence intervals (CIs) for the occurrence of ≥1 and ≥2 different nonfocal TNAs. Adjustments were made for age, sex, systolic blood pressure and time interval between most recent TIA or ischemic stroke and questionnaire, as these factors were considered a priori to be potential confounders of the association between CAO and the occurrence of nonfocal TNAs. Subgroup analyses were performed in patients without steno-occlusion of the vertebral arteries, and in patients with CAO who also had had a contralateral carotid or vertebral artery steno-occlusion versus patients without any carotid or vertebral artery steno-occlusion.

Results {#sec6-2396987318818779}
=======

We included 67 patients with CAO and 62 patients without CAO. Mean age was 66 (±9) years. Patients with CAO were more often male, had more vascular risk factors and had higher systolic blood pressure than those without CAO ([Table 2](#table2-2396987318818779){ref-type="table"}). Seven (11%) of patients with CAO had a contralateral asymptomatic carotid artery stenosis of ≥50% and six (9%) had a contralateral CAO. Fifteen (23%) patients with CAO also had \>50% stenosis of a vertebral artery.

###### 

Patient characteristics.

![](10.1177_2396987318818779-table2)

                                                                                                 Carotid occlusion (*n* = 67)                                      No carotid occlusion (*n* = 62)
  ---------------------------------------------------------------------------------------------- ----------------------------------------------------------------- ----------------------------------------------------------------------
  Age in years, mean (SD)                                                                        65.3 (±7.9)                                                       65.8 (±9.8)
  Male sex, *n* (%)                                                                              51 (76%)                                                          37 (60%)
  Hypertension, *n* (%)                                                                          52 (78%)                                                          39 (63%)
  Hyperlipidemia, *n* (%)                                                                        61 (91%)                                                          24 (39%)
  Current smoking, *n* (%)                                                                       17 (25%)                                                          11 (18%)^[a](#table-fn3-2396987318818779){ref-type="table-fn"}^
  Diabetes mellitus, *n* (%)                                                                     21 (31%)                                                          11 (18%)
  History of, *n* (%)                                                                                                                                              
   Myocardial infarction                                                                         9 (13%)                                                           5 (8%)
   Peripheral arterial disease                                                                   21 (31%)                                                          2 (3%)
   TIA (including amaurosis fugax)                                                               50 (75%)                                                          22 (36%)
   Ischemic stroke                                                                               38 (57%)                                                          42 (68%)
  Medication use, *n* (%)                                                                                                                                          
   Antiplatelet                                                                                  56 (84%)                                                          48 (77%)
   Anticoagulant                                                                                 6 (9%)                                                            10 (16%)
   Antihypertensive                                                                              47 (70%)                                                          32 (52%)
   Lipid lowering                                                                                59 (88%)                                                          50 (81%)
  Systolic blood pressure in mmHg, mean (SD)                                                     152.1 (±21.1)                                                     136.3 (±15.0)^[b](#table-fn4-2396987318818779){ref-type="table-fn"}^
  Diastolic blood pressure in mmHg, mean (SD)                                                    82.7 (±12.1)                                                      80.3 (±10.8)^[b](#table-fn4-2396987318818779){ref-type="table-fn"}^
  Stenosis of extracranial cerebral arteries, *n* (%)                                                                                                              
   Contralateral ICA stenosis ≥50% or occlusion                                                  13 (20%)^[c](#table-fn5-2396987318818779){ref-type="table-fn"}^   NA
   VA stenosis ≥50% or occlusion                                                                 15 (23%)^[c](#table-fn5-2396987318818779){ref-type="table-fn"}^   3 (5%)
  Side of symptomatic carotid occlusion, *n* (%)                                                                                                                   
   Right                                                                                         31 (46%)                                                          NA
   Left                                                                                          30 (45%)                                                          NA
  Both                                                                                           6 (9%)                                                            NA
  Interval between most recent TIA or ischemic stroke and questionnaire in years, median (IQR)   3.7 (1.9--8.9)                                                    1.8 (1.0--10.5)

SD: standard deviation; TIA: transient ischemic attack; ICA: internal carotid artery; VA: vertebral artery; IQR: interquartile range; NA: not applicable.

^a^Missing in *n* = 1 (2%).

^b^Blood pressure was measured before administration of questionnaire (\<1 year earlier).

^c^Missing in *n* = 3 (5%).

[Table 1](#table1-2396987318818779){ref-type="table"} summarizes the different nonfocal symptoms. Forty-three of all patients (33%) had had one or more nonfocal TNAs in the preceding six months (Supplementary Figure 1). The prevalence of at least one nonfocal TNA was not significantly different between patients with and without CAO (39% vs. 27%; adjusted RR 1.47, 95% CI 0.83--2.61; [Table 3](#table3-2396987318818779){ref-type="table"}). However, the prevalence of two or more different nonfocal TNAs was significantly higher in patients with CAO (16% vs. 3%; adjusted RR 4.77, 95% CI 1.20--18.98; [Table 3](#table3-2396987318818779){ref-type="table"}).

###### 

Occurrence of nonfocal TNAs in the past six months in patients with and without CAO, and in the subgroup of patients without vertebral artery stenosis or occlusion.

![](10.1177_2396987318818779-table3)

  All patients                                       Carotid occlusion (*n* = 67)   No carotid occlusion (*n* = 62)   RR crude (95% CI)    RR adjusted (95% CI)
  -------------------------------------------------- ------------------------------ --------------------------------- -------------------- ---------------------------------------------------------------------------
  Occurrence of ≥1 different TNA symptoms, *n* (%)   26 (39%)                       17 (27%)                          1.42 (0.86--2.34)    1.47 (0.83--2.61)^[a](#table-fn7-2396987318818779){ref-type="table-fn"}^
  Occurrence of ≥2 different TNA symptoms, *n* (%)   11 (16%)                       2 (3%)                            5.09 (1.17--22.06)   4.77 (1.20--18.98)^[b](#table-fn8-2396987318818779){ref-type="table-fn"}^
  No VA steno-occlusion                              Carotid occlusion (*n*=49)     No carotid occlusion (*n*=59)     RR crude(95% CI)     RR adjusted(95% CI)
  Occurrence of ≥1 different TNA symptoms, *n* (%)   16 (33%)                       16 (27%)                          1.20 (0.67--2.15)    1.08 (0.56--2.10)^[a](#table-fn7-2396987318818779){ref-type="table-fn"}^
  Occurrence of ≥2 different TNA symptoms, *n* (%)   8 (16%)                        2 (3%)                            4.82 (1.07--21.64)   4.02 (0.99--16.35)^[b](#table-fn8-2396987318818779){ref-type="table-fn"}^

TNA: transient neurological attack; CAO: carotid artery occlusion; RR: risk ratio; CI: confidence interval; VA: vertebral artery.

^a^Adjusted for age, sex, systolic blood pressure, time interval between most recent TIA or ischemic stroke and questionnaire.

^b^Adjusted for systolic blood pressure, time interval between most recent TIA or ischemic stroke and questionnaire.

Exclusion of patients with vertebral artery steno-occlusion (*n* = 21, 16%) yielded comparable results ([Table 3](#table3-2396987318818779){ref-type="table"}). In a post-hoc analysis, nonfocal TNAs occurred more often in patients with both CAO and a contralateral carotid or vertebral artery steno-occlusion (*n* = 28) than in patients without any carotid or vertebral artery steno-occlusion (*n* = 59) (46% vs. 27%; adjusted RR 2.22, 95% CI 1.08--4.60 for ≥1 and 21% vs. 3%; adjusted RR 8.27, 95% CI 1.83--37.32 for ≥2 nonfocal TNAs) ([Table 4](#table4-2396987318818779){ref-type="table"}).

###### 

Occurrence of nonfocal TNAs in the past six months in patients with CAO and VA or contralateral carotid steno-occlusion and in those without CAO and without VA steno-occlusion.

![](10.1177_2396987318818779-table4)

                                                   Carotid occlusion^[a](#table-fn10-2396987318818779){ref-type="table-fn"}^ (*n* = 28)   No steno- occlusion^[b](#table-fn11-2396987318818779){ref-type="table-fn"}^ (*n* = 59)   RR crude (95% CI)    RR adjusted (95% CI)
  ------------------------------------------------ -------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------- -------------------- ----------------------------------------------------------------------------
  Occurrence of ≥1 different TNA symptoms, n (%)   13 (46%)                                                                               16 (27%)                                                                                 1.71 (0.96--3.05)    2.22 (1.08--4.60)^[c](#table-fn12-2396987318818779){ref-type="table-fn"}^
  Occurrence of ≥2 different TNA symptoms, n (%)   6 (21%)                                                                                2 (3%)                                                                                   6.32 (1.36--29.36)   8.27 (1.83--37.32)^[d](#table-fn13-2396987318818779){ref-type="table-fn"}^

TNA: transient neurological attack; CAO: carotid artery occlusion; VA: vertebral artery; RR: risk ratio; CI: confidence interval.

^a^Patients with both CAO and a contralateral carotid artery steno-occlusion or vertebral artery steno-occlusion.

^b^Patients without steno-occlusion of the carotid and vertebral arteries.

^c^Adjusted for age, sex, systolic blood pressure, time interval between most recent TIA or ischemic stroke and questionnaire.

^d^Adjusted for systolic blood pressure, time interval between most recent TIA or ischemic stroke and questionnaire.

Discussion {#sec7-2396987318818779}
==========

We found that one-third of patients with a distant history of TIA or nondisabling ischemic stroke of the anterior circulation experienced nonfocal TNAs in the preceding six months. The prevalence of multiple nonfocal TNAs was higher in patients with CAO than in those patients without CAO. Also, the prevalence of one or more nonfocal TNAs was higher in patients with CAO who also had a contralateral carotid or vertebral artery steno-occlusion than in patients without any cerebropetal steno-occlusion.

Studies on the prevalence of nonfocal TNAs are limited. In a previous population-based study, 2% of patients (\>55 years) experienced a nonfocal TNA in the preceding three years.^[@bibr1-2396987318818779]^ In another hospital-based study, nonfocal symptoms occurred more frequently in patients with a recent TIA or nondisabling ischemic stroke; 20% of patients without carotid or vertebral artery stenosis, 36% of patients with carotid artery stenosis and 54% of patients with vertebral artery stenosis experienced nonfocal TNAs in the six months preceding the cerebral ischemic event.^[@bibr10-2396987318818779]^ Our findings are compatible with these results.

Although we can only hypothesize, the higher prevalence of multiple nonfocal TNAs in patients with versus without CAO might be caused by cerebral hypoperfusion due to CAO. Our finding that these differences in prevalence were even more profound in patients with both CAO and a contralateral carotid or vertebral artery steno-occlusion supports a hemodynamic etiology.

Our study has some limitations. To start, although we tried to make the group without CAO comparable to the CAO group with regards to vascular risk factors and risk of ischemic stroke by including only patients with a distant history of TIA or nondisabling ischemic stroke as our control population, vascular risk factors and previous vascular diseases were more often present in the CAO group. Although we cannot rule out residual confounding, we have adjusted our analysis for those variables that we considered potential confounders of the association between presence of CAO and occurrence of nonfocal TNAs. Second, the time interval between the most recent cerebral ischemic event and administration of the questionnaire was longer in patients with CAO than in patients without CAO. Patients with a more recent event may have been more aware of what symptoms they experienced in the previous six months which may have underestimated the prevalence of nonfocal TNAs in patients with CAO. However, this would only have enhanced the difference between patients with and without CAO and adjustment for this time interval did not have a large influence on the effect estimates. Third, the diagnosis of a nonfocal TNA can be difficult and the questionnaire was administered by several different unblinded interviewers which carries the risk of misclassification. However, we used a standardized questionnaire and systematically asked for nonfocal TNAs. Last, we had no detailed information regarding diagnostic examinations in patients with nonfocal TNAs and as such could not be completely sure that other diagnoses were ruled out.

In conclusion, our study indicates that nonfocal TNAs are highly common in patients with a distant TIA or nondisabling stroke. Patients with CAO experience multiple nonfocal TNAs more often than patients without CAO. Since nonfocal TNAs are highly prevalent and it is unknown whether they should be a reason to adapt clinical management, future research is needed to understand underlying mechanisms and prognosis.
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